Current routine histopathologic methods may fail in detecting lymph node micrometastases, while the introduction of newer, sensitive techniques, such as immunohistochemistry and molecular analysis, can improve their detection. The literature reveals that the presence of micrometastases has clinical and prognostic implications.
Get full access to this article
View all access options for this article.
References
1.
NoguchiSAiharaTMotomuraKInajiHImaokaSKoyamaH. Histologie characteristics of breast cancers with occult lymph node metastases detected by keratin 19 mRNA reverse transcriptase-polymerase chain reaction. Cancer1996; 78: 1235–40.
2.
ReintgenDShiversS. Sentinel lymph node micrometastasis from melanoma. Proven methodology and evolving significance [Editorial]. Cancer1999; 86: 551–2.
3.
CzernieckiBJScheffAMCallansLS. Immuno-histochemistry with pancytokeratins improves the sensitivity of sentinel lymph node biopsy in patients with breast carcinoma. Cancer1999; 85: 1098–103.
4.
ByersRMWeberRSAndrewsTMcGillDKareRWolfP. Frequency and therapeutic implications of “skip metastases” in the neck from squamous carcinoma of the oral tongue. Head Neck1997; 19: 14–9.
5.
TrojaniMde MascarelIBonichonFCoindreJMDelsolG. Micrometastases to axillary lymph nodes from carcinoma of breast: detection by immunohistochemistry and prognostic significance. Br J Cancer1987; 55: 303–6.
6.
International (Ludwig) Breast Cancer Study Group. Prognostic importance of occult axillary lymph node micrometastases from breast cancers. Lancet1990; 335: 1565–8.
7.
IshidaKKatsuyamaTSugiyamaAKawasakiS. Immunohistochemical evaluation of lymph node micrometastases from gastric carcinomas. Cancer1997; 79: 1069–76.
8.
O'SullivanGCCollinsJKKellyJMorganJMaddenMShanahanF. Micrometastases: marker of metastatic potential or evidence of residual disease?. Gut1997; 40: 512–5.
9.
NatsugoeSMuellerJSteinHJFeithMHöflerHSiewertJR. Micrometastasis and tumor cell microinvolvement of lymph nodes from esophageal squamous cell carcinoma. Frequency, associated tumor characteristics, and impact on prognosis. Cancer1998; 83: 858–66.
10.
GlickmanJNTorresCWangHH. The prognostic significance of lymph node micrometastasis in patients with esophageal carcinoma. Cancer1999; 85: 769–78.
11.
YokoyamaNShiraiYHatakeyamaK. Immunohistochemical detection of lymph node micrometastases from gallbladder carcinoma using monoclonal anticytokeratin antibody. Cancer1999; 85: 1465–9.
12.
HuvosAGHutteRVPBergJW. Significance of axillary macrometastases and micrometastases in mammary cancer. Ann Surg1971; 173: 44–6.
13.
FisherERSwamidossSLeeCHRocketteHRedmondCFisherB. Detection and significance of occult axillary node metastases in patients with invasive breast cancer. Cancer1978; 42: 2025–31.
14.
FriedmanSBertinFMouriesseH. Importance of tumor cells in axillary node sinus margins (“clandestine” metastases) discovered by serial sectioning in operable breast carcinoma. Acta Oncol1988; 27: 483–7.
15.
de MascarelIBonichonFCoindreJMTrojaniM. Prognostic significance of breast cancer axillary lymph node micrometastases assessed by two special techniques: reevaluation with longer follow-up. Br J Cancer1992; 66: 523–7.
16.
ElsonCEKufeDJohnstonWW. Immunohistochemical detection and significance of axillary lymph node micrometastases in breast carcinoma. A study of 97 cases. Anal Quant Cytol Histol1993; 15: 171–8.
17.
RosenPSaigoPBraunDWeathersEFracchiaAKinneD. Axillary micro- and macrometastasis in breast cancer: prognostic significance of tumor size. Ann Surg1981; 194: 585–91.
18.
SedmakDMeinekeTKnetchgasDAndersonJ. Prognostic significance of cytokeratin positive breast cancer. Mod Pathol1989; 2: 516–20.
19.
McGuckinMACummingsMCWalshMDHohnBGBennettICWrightRG. Occult axillary node metastases in breast cancer: their detection and prognostic significance. Br J Cancer1996; 73: 88–95.
20.
GerberBKrauseAReimerT. Immunohistochemically detected lymph-node micrometastasis in breast cancer and their correlation with prognostic factors. Breast J1997; 3: 106–11.
21.
BussolatiGGugliottaPMorraIPierribiasiFBerar-DengoE. Immunohistochemical detection of lymph node metastases from infiltrating lobular carcinoma of the breast. Br J Cancer1986; 54: 631–6.
22.
SchurmanSHSharonNGoldschmidtRAScanionEF. Improved detection of metastases to lymph nodes and estrogen receptor determination. Arch Surg1990; 125: 179–82.
23.
ChenZLWenDRCoulsonWFGiulianoAECochranAJ. Occult metastases in the axillary lymph nodes of patients with breast cancer node negative by clinical and histologic examination and conventional histology. Dis Markers1991; 9: 239–48.
24.
HainsworthPJTjandraJJStillwellRG. Detection and significance of occult metastases in node-negative breast cancer. Br J Surg1993; 80: 459–63.
25.
NasserIALeeAKCBosariSSaganichRHeatleyGSilvermanM. Occult axillary lymph node metastases in “node negative” breast carcinoma. Hum Pathol1993; 24: 950–7.
26.
BrennanJAMaoLHrubanRH. Molecular assessment of histopathological staging in squamous-cell carcinoma of the head and neck. N Engl J Med1995; 332: 429–35.
27.
MoriMMimoriKInoueH. Detection of cancer micrometastases in lymph nodes by reverse transcriptase-polymerase chain reaction. Cancer Res1995; 55: 3417–20.
28.
IzbickiJRHoschSBPichlmeierU. Prognostic value of immunohistochemically identifiable tumor cells in lymph nodes of patients with completely resected esophageal cancer. N Engl J Med1997; 337: 1188–94.
29.
DemeureMJDoffekKMKomorowskiRAWilsonSD. Adenocarcinoma of the pancreas. Cancer1998; 83: 1328–34.
30.
LuketichJDKassisESShriverSP. Detection of micrometastases in histologically negative lymph nodes in esophageal cancer. Ann Thorac Surg1998; 66: 1715–8.
31.
van den BrekelMWMStelHVvan der ValkPvan der WaalIMeyerCJLMSnowGB. Micrometastases from squamous cell carcinoma in neck dissection specimens. Eur Arch Otorhinolaryngol1992; 249: 349–53.
32.
AmbroschPBrinckU. Detection of nodal micrometastases in head and neck cancer by serial sectioning and immunostaining. Oncology (Huntingt)1996; 10: 1221–9.
33.
EnepekidesDJSultanemKNguyenCShenoudaGBlackMJRochonL. Occult cervical metastases: immunoper-oxidase analysis of the pathologically negative neck. Otolaryngol Head Neck Surg1999; 120: 713–7.
34.
BrennanJASidranskyD. Molecular staging of head and neck squamous carcinoma. Cancer Metastasis Rev1996; 15: 3–10.
